Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

Bladder issues are a daily reality for many with MS, writes columnist Desiree Lama, who encourages more open discussion about the topic.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

A new community-led network called PRADA enables underrepresented patients living with MS to help set research priorities.

Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

A collaboration will test whether changes in a person’s voice can help detect multiple sclerosis, potentially enabling a ...

After struggling during seasons when MS took center stage, columnist Ahna Crum is enjoying the quieter days where it's only ...

TG Therapeutics is gearing up for a new clinical trial, dubbed ULTIMATE, to test Briumvi in children and adolescents with ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

Immunic raised funds to support Phase 3 clinical trials of vidofludimus calcium for MS and transition into a commercial-stage company.